These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34690897)

  • 1. Norms According to Age and Gender for the Spanish Version of the Inventory of Depression and Anxiety Symptoms (IDAS-II).
    Sanchez-Garcia M; De la Rosa-Cáceres A; Stasik-O'Brien S; Mancheño-Barba JJ; Lozano ÓM; Diaz-Batanero C
    Front Psychol; 2021; 12():748025. PubMed ID: 34690897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spanish Adaptation of the Inventory of Depression and Anxiety Symptoms (IDAS-II) and a study of its psychometric properties.
    De la Rosa-Cáceres A; Stasik-O'Brien S; Rojas AJ; Sanchez-Garcia M; Lozano OM; Díaz-Batanero C
    J Affect Disord; 2020 Jun; 271():81-90. PubMed ID: 32479335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Internalizing Symptoms and Their Relation with Levels of Impairment: Evidence-Based Cutoffs for Interpreting Inventory of Depression and Anxiety Symptoms (IDAS-II) Scores.
    De la Rosa-Cáceres A; Lozano OM; Sanchez-Garcia M; Fernandez-Calderon F; Rossi G; Diaz-Batanero C
    J Psychopathol Behav Assess; 2023; 45(1):170-180. PubMed ID: 36644288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the expanded version of the inventory of depression and anxiety symptoms (IDAS-II) in a sample of older adults.
    Weitzner D; Calamia M; Stasik-O'Brien SM; De Vito A; Pugh E
    Aging Ment Health; 2020 Nov; 24(11):1847-1853. PubMed ID: 31264444
    [No Abstract]   [Full Text] [Related]  

  • 5. National norms for the expanded version of the inventory of depression and anxiety symptoms (IDAS-II).
    Nelson GH; O'Hara MW; Watson D
    J Clin Psychol; 2018 Jun; 74(6):953-968. PubMed ID: 29327338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the Inventory of Depression and Anxiety Symptoms-II-German version.
    Wester RA; Rubel J; Zimmermann J; Hall M; Kaven L; Watson D
    Psychol Assess; 2022 Dec; 34(12):e88-e99. PubMed ID: 36521138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS).
    Watson D; O'Hara MW; Simms LJ; Kotov R; Chmielewski M; McDade-Montez EA; Gamez W; Stuart S
    Psychol Assess; 2007 Sep; 19(3):253-68. PubMed ID: 17845118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor structure and validity of the Inventory of Depression and Anxiety Symptoms-II (IDAS-II) in a chronic back pain treatment-seeking sample.
    Kaye S; Wygant DB; Umlauf RL; Marek RJ
    Psychol Assess; 2022 Jan; 34(1):3-9. PubMed ID: 34292002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further validation of the IDAS: evidence of convergent, discriminant, criterion, and incremental validity.
    Watson D; O'Hara MW; Chmielewski M; McDade-Montez EA; Koffel E; Naragon K; Stuart S
    Psychol Assess; 2008 Sep; 20(3):248-59. PubMed ID: 18778161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of new anxiety and bipolar symptom scales for an expanded version of the IDAS (the IDAS-II).
    Watson D; O'Hara MW; Naragon-Gainey K; Koffel E; Chmielewski M; Kotov R; Stasik SM; Ruggero CJ
    Assessment; 2012 Dec; 19(4):399-420. PubMed ID: 22822173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of the Inventory of Depression and Anxiety Symptoms (IDAS).
    Stasik-O'Brien SM; Brock RL; Chmielewski M; Naragon-Gainey K; Koffel E; McDade-Montez E; O'Hara MW; Watson D
    Assessment; 2019 Jul; 26(5):944-960. PubMed ID: 30043620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking-related correlates of depressive symptom dimensions in treatment-seeking smokers.
    Leventhal AM; Zvolensky MJ; Schmidt NB
    Nicotine Tob Res; 2011 Aug; 13(8):668-76. PubMed ID: 21471305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey.
    Terluin B; Smits N; Brouwers EP; de Vet HC
    Health Qual Life Outcomes; 2016 Sep; 14(1):130. PubMed ID: 27629535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of somatic symptoms as indicators of depression in pregnancy.
    Nylen KJ; Williamson JA; O'Hara MW; Watson D; Engeldinger J
    Arch Womens Ment Health; 2013 Jun; 16(3):203-10. PubMed ID: 23456541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety and depression symptoms in the same pregnant women before and during the COVID-19 pandemic.
    Ayaz R; Hocaoğlu M; Günay T; Yardımcı OD; Turgut A; Karateke A
    J Perinat Med; 2020 Nov; 48(9):965-970. PubMed ID: 32887191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the Spanish version of the Geriatric Anxiety Inventory.
    Márquez-González M; Losada A; Fernández-Fernández V; Pachana NA
    Int Psychogeriatr; 2012 Jan; 24(1):137-44. PubMed ID: 21813040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-measure equivalence and communicability in the assessment of depression: a focus on factor-based scales.
    González DA; Jenkins SR
    Assessment; 2014 Dec; 21(6):731-41. PubMed ID: 24586091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Failure effects and gender differences in perfectionism].
    Masson AM; Cadot M; Ansseau M
    Encephale; 2003; 29(2):125-35. PubMed ID: 14567164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between emotional symptoms and self-reported aberrant driving behaviors in older adults.
    Bernstein JPK; DeVito A; Calamia M
    Accid Anal Prev; 2019 Jun; 127():28-34. PubMed ID: 30826694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of suppressor effects in explicating the construct validity of symptom measures.
    Watson D; Clark LA; Chmielewski M; Kotov R
    Psychol Assess; 2013 Sep; 25(3):929-941. PubMed ID: 23795886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.